Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CAH 
Cardinal Health Inc (CAH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/31/2025: CAH (5-star) is a STRONG-BUY. BUY since 22 days. Simulated Profits (20.39%). Updated daily EoD!
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
17 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $196.21
1 Year Target Price $196.21
| 9 | Strong Buy |
| 2 | Buy |
| 5 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 60.6% | Avg. Invested days 48 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/31/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 45.33B USD | Price to earnings Ratio 28.73 | 1Y Target Price 196.21 |
Price to earnings Ratio 28.73 | 1Y Target Price 196.21 | ||
Volume (30-day avg) 17 | Beta 0.72 | 52 Weeks Range 109.06 - 197.67 | Updated Date 11/2/2025 |
52 Weeks Range 109.06 - 197.67 | Updated Date 11/2/2025 | ||
Dividends yield (FY) 1.07% | Basic EPS (TTM) 6.64 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-31 | When Before Market | Estimate 2.18 | Actual 2.55 |
Profitability
Profit Margin 0.68% | Operating Margin (TTM) 1.21% |
Management Effectiveness
Return on Assets (TTM) 3.44% | Return on Equity (TTM) - |
Valuation
Trailing PE 28.73 | Forward PE 16.92 | Enterprise Value 42300351789 | Price to Sales(TTM) 0.19 |
Enterprise Value 42300351789 | Price to Sales(TTM) 0.19 | ||
Enterprise Value to Revenue 0.19 | Enterprise Value to EBITDA 13.62 | Shares Outstanding 237595042 | Shares Floating 237179251 |
Shares Outstanding 237595042 | Shares Floating 237179251 | ||
Percent Insiders 0.25 | Percent Institutions 88.61 |
Upturn AI SWOT
Cardinal Health Inc
Company Overview
History and Background
Cardinal Health was founded in 1971 as Cardinal Foods, a food wholesaler. It entered the drug distribution business in 1979. Through acquisitions and organic growth, it evolved into a leading healthcare services company.
Core Business Areas
- Pharmaceutical Distribution: Distributes branded and generic pharmaceutical products, specialty pharmaceuticals, and over-the-counter healthcare products to pharmacies, hospitals, and healthcare providers.
- Medical Segment: Provides medical products and devices, including wound care, infection control, and surgical products, to hospitals, surgery centers, and other healthcare facilities. Manages logistic services.
Leadership and Structure
The CEO is Jason Hollar. The company operates with a functional organizational structure, with distinct leadership for each business segment and supporting functions like finance and operations.
Top Products and Market Share
Key Offerings
- Pharmaceutical Distribution: Distributes pharmaceuticals to a network of pharmacies, hospitals, and healthcare providers. Cardinal Health holds a significant share of the pharmaceutical distribution market in the US. Competitors include McKesson and AmerisourceBergen. Revenue from this segment dominates overall revenue.
- Medical Products and Services: Offers a range of medical, surgical, and laboratory products. This includes Cardinal Health branded products and products from other manufacturers. This segment is slightly more competitive due to the high volume of medical suppliers. McKesson, Medline Industries, and Owens & Minor compete in this space.
Market Dynamics
Industry Overview
The pharmaceutical distribution and medical device industries are consolidating, with increasing regulatory scrutiny and pricing pressures. Growth is driven by an aging population and increased healthcare spending.
Positioning
Cardinal Health is one of the largest pharmaceutical distributors and medical product suppliers in the US, with a strong market position and extensive distribution network. They leverage scale for cost efficiencies. Their diversification into medical products provides some buffer to pharmaceutical pricing pressures.
Total Addressable Market (TAM)
The global pharmaceutical distribution market is estimated to be around $700 billion, and the medical device market is similarly sized. Cardinal Health's revenue gives it a significant, but not dominant, position in relation to these TAMs.
Upturn SWOT Analysis
Strengths
- Large scale and market share
- Extensive distribution network
- Diversified product portfolio
- Strong customer relationships
Weaknesses
- Exposure to pharmaceutical pricing pressures
- Dependence on key suppliers
- Litigation risks related to opioid distribution
- Profit margins can be relatively thin.
Opportunities
- Expansion into specialty pharmaceuticals
- Growth in emerging markets
- Increased demand for healthcare services
- Further acquisitions to expand product offerings
Threats
- Increased competition
- Government regulation of drug prices
- Supply chain disruptions
- Economic downturn
Competitors and Market Share
Key Competitors
- MCK
- ABC
- CVS
Competitive Landscape
Cardinal Health competes with other large pharmaceutical distributors like McKesson and AmerisourceBergen. Its competitive advantages include its scale, distribution network, and diversified product portfolio. It faces challenges from pricing pressures and regulatory scrutiny.
Major Acquisitions
AssuraMed
- Year: 2013
- Acquisition Price (USD millions): 2070
- Strategic Rationale: Expanded Cardinal Health's presence in the home healthcare market.
Growth Trajectory and Initiatives
Historical Growth: Cardinal Health has grown through acquisitions and organic growth. However, recent growth has been impacted by pricing pressures and supply chain issues.
Future Projections: Future growth is projected to be moderate, driven by increasing healthcare spending and expansion into new markets and services. Analyst estimates should be consulted for specific projections.
Recent Initiatives: Recent strategic initiatives include investments in technology and automation to improve efficiency and expansion into specialty pharmaceutical services.
Summary
Cardinal Health is a major player in pharmaceutical distribution and medical products with a strong market presence. While its scale and network are advantages, it faces challenges from pricing pressures and opioid litigation. Expanding into specialty pharmaceuticals and managing supply chain risks are key for future growth. The company is fairly strong based on its market position, but must successfully navigate the challenges ahead.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cardinal Health Inc
Exchange NYSE | Headquaters Dublin, OH, United States | ||
IPO Launch date 1987-12-31 | CEO & Director Mr. Jason M. Hollar | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 53084 | Website https://www.cardinalhealth.com |
Full time employees 53084 | Website https://www.cardinalhealth.com | ||
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.